<p>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder clinically characterized by rapidly progressive paralysis and death due to respiratory failure, typically within two to three years of symptom onset. The number of ALS cases across the globe will increase to nearly 400,000 in 2040, predominantly due to aging of the population. Unraveling the genetics underlying ALS provides insights into the cellular mechanism leading to motor neuron death and provides targets for therapeutic intervention.</p> <p>We performed a genome-wide association study involving a meta-analysis of 20,806 ALS cases and 59,804 controls. The current study release makes available genotype data of the 15,480 subjects assayed in the Laboratory of Neurogenetics for this effort.</p>

Genome-Wide Association Study of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis study with SNP Genotypes (Array), SNP Genotypes (NGS) + 1 more data on dbGaP (15,480 participants)

Genome-Wide Association Study of Amyotrophic Lateral Sclerosis

Description

Applying For Access

Summary